Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Understand the recommended order of withdrawals from index funds to minimize taxes over retirement.
15,857 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Could Palantir’s stock be meaningfully higher by 2027? This article offers a grounded forecast with base, bull, and b...
Nike has fallen sharply from its peak, but a blue-chip brand can still offer compelling upside. This guide analyzes t...
Ripple has spent close to $3 billion on acquisitions since 2023 to build out institutional rails. The moves aim to em...
In a choppy crypto market, Zcash faced a dramatic turn after its development team resigned amid board tensions. This ...
Trilogy Metals stock tanked after a tepid earnings release, shaking confidence in a company that explores copper, gol...
Russia is moving to block foreign crypto exchanges unless they comply with new domestic regulations, aiming to funnel...
Navigate Neptune's Q4 2025 performance, understand margin dynamics, and gauge 2026 guidance. This practical guide exp...
A new institutional stake in Howard Hughes Holdings suggests rising confidence in the stock. With 140,268 shares boug...
Public disputes can hit more than pride—they touch brand value and bank balances. Learn how chris brown avoids “inter...
Bridgewater Associates tightened its tech exposure in the latest 13F filing, cutting stakes in Microsoft, Meta, and A...
Salesforce stock faces a pivotal year as AI-enhanced CRM and cloud strategy shape the upside. Here's the latest marke...